These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2485249)

  • 1. Substance P antagonists block carbachol-induced "boxing" behavior at a site of coexistence in the rat prefrontal cortex.
    Stivers JA; Crawley JN
    Peptides; 1988; 9 Suppl 1():117-21. PubMed ID: 2485249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral investigation of the coexistence of substance P, corticotropin releasing factor, and acetylcholinesterase in lateral dorsal tegmental neurons projecting to the medial frontal cortex of the rat.
    Crawley JN; Olschowka JA; Diz DI; Jacobowitz DM
    Peptides; 1985; 6(5):891-901. PubMed ID: 2417203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substance-P antagonists: effect on spontaneous and drug-induced locomotor activity in the rat.
    Elliott PJ; Iversen SD
    Neuropharmacology; 1987 May; 26(5):419-22. PubMed ID: 2439936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anatomical analysis of frontal cortex sites at which carbachol induces motor seizures in the rat.
    Stivers JA; Skirboll LR; Long R; Crawley JN
    Pharmacol Biochem Behav; 1988 May; 30(1):129-36. PubMed ID: 3174734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
    Reid MS; Herrera-Marschitz M; Hökfelt T; Ohlin M; Valentino KL; Ungerstedt U
    Neuroscience; 1990; 36(3):643-58. PubMed ID: 1700329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substance P analogues containing D-histidine antagonize the behavioural effects of intrathecally co-administered substance P in mice.
    Sakurada T; Yamada T; Sakurada S; Kisara K; Ohba M
    Eur J Pharmacol; 1989 Dec; 174(2-3):153-60. PubMed ID: 2483548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of slow excitatory post-synaptic potential by substance P antagonists in guinea-pig sympathetic ganglia.
    Konishi S; Otsuka M
    J Physiol; 1985 Apr; 361():115-30. PubMed ID: 2580973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonists of substance P. Further modifications of substance P antagonists obtained by replacing either positions 7, 9 or 7, 8 and 11 of SP with D-amino acid residues.
    Dutta AS; Gormley JJ; Graham AS; Briggs I; Growcott JW; Jamieson A
    J Med Chem; 1986 Jul; 29(7):1171-8. PubMed ID: 2433443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of substance P antagonists with substance P receptors on dispersed pancreatic acini.
    Jensen RT; Jones SW; Lu YA; Xu JC; Folkers K; Gardner JD
    Biochim Biophys Acta; 1984 Jun; 804(2):181-91. PubMed ID: 6202326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substance P in the dorsal vagal complex inhibits medullary TRH-induced gastric acid secretion in rats.
    Yang H; Taché Y
    Am J Physiol; 1997 May; 272(5 Pt 1):G987-93. PubMed ID: 9176205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species differences in the behavioral toxicity produced by intrathecal substance P antagonists: relationship to analgesia.
    Vaught JL; Scott R
    Life Sci; 1987 Jan; 40(2):175-81. PubMed ID: 2432377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do local vasomotor effects elicit the motor deficits induced by intrathecally applied substance P antagonists in the rat?
    Barber A; Wild A; Wedel R
    Neurosci Lett; 1987 Sep; 80(2):219-23. PubMed ID: 2446208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of [D-Pro2, D-Phe7, D-Trp9]-substance P and [D-Trp7,9]-substance P as tachykinin partial agonists in the rat colon.
    Bailey SJ; Jordan CC
    Br J Pharmacol; 1984 Jun; 82(2):441-51. PubMed ID: 6203595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of spinal cord substance P: studies with a stable receptor agonist.
    Keeler JR; Charlton CG; Helke CJ
    J Pharmacol Exp Ther; 1985 Jun; 233(3):755-60. PubMed ID: 2409270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of substance P antagonists with serotonin in the mouse spinal cord.
    Vaught JL; Scott R
    Peptides; 1988; 9(4):909-13. PubMed ID: 2465543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensory and motor functions of spinal cord substance P.
    Piercey MF; Schroeder LA; Folkers K; Xu JC; Horig J
    Science; 1981 Dec; 214(4527):1361-3. PubMed ID: 6171882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galanin antagonists block galanin-induced feeding in the hypothalamus and amygdala of the rat.
    Corwin RL; Robinson JK; Crawley JN
    Eur J Neurosci; 1993 Nov; 5(11):1528-33. PubMed ID: 7506975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the substance P antagonist, (D-Arg1, D-Pro2, D-Trp7,9, Leu11)-SP on the miotic response to substance P, antidromic trigeminal nerve stimulation, capsaicin, prostaglandin E1, compound 48/80 and histamine.
    Mandahl A; Bill A
    Acta Physiol Scand; 1984 Jan; 120(1):27-35. PubMed ID: 6202097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tachykinin receptors mediate atropine-resistant rat duodenal reflex contractions in vivo.
    Giuliani S; Tramontana M; Lecci A; Maggi CA
    Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):327-35. PubMed ID: 8878063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tachykinins may modify spontaneous epileptiform activity in the rat entorhinal cortex in vitro by activating GABAergic inhibition.
    Maubach KA; Cody C; Jones RS
    Neuroscience; 1998 Apr; 83(4):1047-62. PubMed ID: 9502245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.